Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BANK OF AMERICA CORP /DE/
Report date February 22, 2005 · Filed February 24, 2005
Section 16 reporting ended · disclosed 2005-02-24. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 5,732.58 |
Reported balance
After 2005-02-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2005-02-22 · Other · Disposed 740.38 · Balance 5,732.58 F1: Units returned to the Corporation related to termination of service as a director. F2: Phantom stock units may be settled in cash upon death or termination of service as a director. F3: Includes 126.58 phantom stock units acquired in 2004 with reinvested dividend equivalents under the Bank of America Directors' St ock Plan. F4: The securities included in this report and future reports reflect the Company's 2 for 1 stock split on August 27, 2004. |
Filing footnotes · ownership attribution and instrument terms
F1: Units returned to the Corporation related to termination of service as a director.
F2: Phantom stock units may be settled in cash upon death or termination of service as a director.
F3: Includes 126.58 phantom stock units acquired in 2004 with reinvested dividend equivalents under the Bank of America Directors' St ock Plan.
F4: The securities included in this report and future reports reflect the Company's 2 for 1 stock split on August 27, 2004.
MONSANTO CO /NEW/
Report date June 07, 2018 · Filed June 07, 2018
Section 16 reporting ended · disclosed 2018-06-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 1
1 source rowRow 1 · 2018-06-07 · Disposition to issuer · Disposed 7,000 · Balance 0 F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. |
| Deferred Payment Plan Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-06-07 · Disposition to issuer · Disposed 61,622 · Balance 0 F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration").
F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 07, 2018 Filed Jun 7, 2018 16:53 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Disposition to issuerDeferred Payment Plan Restricted Stock Unit · Derivative | 61,622 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-015471 · doc4.xml · derivative · entry 2 MCMILLAN CHARLES S · CIK 0001110756 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 61,622 shares Expires not disclosed F1 · derivative.exercise_price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · derivative.exercise_price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. F1 · price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. F1 · derivative.exercise_date: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · derivative.exercise_date: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. F1 · derivative.expiration_date: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · derivative.expiration_date: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. Read SEC document |
| June 07, 2018 Filed Jun 7, 2018 16:53 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Disposition to issuerCommon Stock | 7,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-015471 · doc4.xml · nonDerivative · entry 1 MCMILLAN CHARLES S · CIK 0001110756 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. Read SEC document |
| April 27, 2018 Filed May 1, 2018 16:21 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | GrantCommon Stock | 265 | $0.00 | $0.00 |
DisclosureSEC source: 0001110783-18-000059 · edgar.xml · nonDerivative · entry 1 MCMILLAN CHARLES S · CIK 0001110756 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,622 F1 · shares: Represents dividend equivalents with respect to shares of deferred common stock deliverable upon termination as a director under the Monsanto Company Non-Employee Director Equity Incentive Compensation Plan. Deferred common stock and dividend equivalents are credited to a stock unit account in the form of hypothetical shares, which vest in installments on the last day of each plan month during the director's term. Shares of deferred stock that do not vest, because of termination as a director or certain changes in committee roles, are forfeited. Read SEC document |
| January 26, 2018 Filed Jan 30, 2018 16:49 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | GrantCommon Stock | 270 | $0.00 | $0.00 |
DisclosureSEC source: 0001110783-18-000030 · edgar.xml · nonDerivative · entry 1 MCMILLAN CHARLES S · CIK 0001110756 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,357 F1 · shares: Represents dividend equivalents with respect to shares of deferred common stock deliverable upon termination as a director under the Monsanto Company Non-Employee Director Equity Incentive Compensation Plan. Deferred common stock and dividend equivalents are credited to a stock unit account in the form of hypothetical shares, which vest in installments on the last day of each plan month during the director's term. Shares of deferred stock that do not vest, because of termination as a director or certain changes in committee roles, are forfeited. Read SEC document |
| October 27, 2017 Filed Oct 30, 2017 16:38 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | GrantCommon Stock | 270 | $0.00 | $0.00 |
DisclosureSEC source: 0001110783-17-000227 · edgar.xml · nonDerivative · entry 1 MCMILLAN CHARLES S · CIK 0001110756 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,087 F1 · shares: Represents dividend equivalents with respect to shares of deferred common stock deliverable upon termination as a director under the Monsanto Company Non-Employee Director Equity Incentive Compensation Plan. Deferred common stock and dividend equivalents are credited to a stock unit account in the form of hypothetical shares, which vest in installments on the last day of each plan month during the director's term. Shares of deferred stock that do not vest, because of termination as a director or certain changes in committee roles, are forfeited. Read SEC document |
| September 01, 2017 Filed Sep 5, 2017 16:28 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | GrantCommon Stock | 2,687 | $117.21 | $314,943.27 |
DisclosureSEC source: 0001110783-17-000154 · edgar.xml · nonDerivative · entry 1 MCMILLAN CHARLES S · CIK 0001110756 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,817 F1 · shares: Represents shares of deferred common stock deliverable upon termination as a director under the Monsanto Company Non-Employee Director Equity Incentive Compensation Plan. Shares of deferred stock are credited in the form of hypothetical shares to a stock unit account in installments on the last day of each plan month during the director's term. Shares of deferred stock not credited to the stock unit account because of termination as a director are forfeited. Read SEC document |
| July 28, 2017 Filed Aug 1, 2017 16:33 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | GrantCommon Stock | 266 | $0.00 | $0.00 |
DisclosureSEC source: 0001110783-17-000130 · edgar.xml · nonDerivative · entry 1 MCMILLAN CHARLES S · CIK 0001110756 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,130 F1 · shares: Represents dividend equivalents with respect to shares of deferred common stock deliverable upon termination as a director under the Monsanto Company Non-Employee Director Equity Incentive Compensation Plan. Deferred common stock and dividend equivalents are credited to a stock unit account in the form of hypothetical shares, which vest in installments on the last day of each plan month during the director's term. Shares of deferred stock that do not vest, because of termination as a director or certain changes in committee roles, are forfeited. Read SEC document |
| April 28, 2017 Filed May 2, 2017 16:19 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | GrantCommon Stock | 267 | $0.00 | $0.00 |
DisclosureSEC source: 0001110783-17-000072 · edgar.xml · nonDerivative · entry 1 MCMILLAN CHARLES S · CIK 0001110756 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,864 F1 · shares: Represents dividend equivalents with respect to shares of deferred common stock deliverable upon termination as a director under the Monsanto Company Non-Employee Director Equity Incentive Compensation Plan. Deferred common stock and dividend equivalents are credited to a stock unit account in the form of hypothetical shares, which vest in installments on the last day of each plan month during the director's term. Shares of deferred stock that do not vest, because of termination as a director or certain changes in committee roles, are forfeited. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 16:22 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | GrantCommon Stock | 283 | $0.00 | $0.00 |
DisclosureSEC source: 0001110783-17-000034 · edgar.xml · nonDerivative · entry 1 MCMILLAN CHARLES S · CIK 0001110756 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,597 F1 · shares: Represents dividend equivalents with respect to shares of deferred common stock deliverable upon termination as a director under the Monsanto Company Non-Employee Director Equity Incentive Compensation Plan. Deferred common stock and dividend equivalents are credited to a stock unit account in the form of hypothetical shares, which vest in installments on the last day of each plan month during the director's term. Shares of deferred stock that do not vest, because of termination as a director or certain changes in committee roles, are forfeited. Read SEC document |
| October 28, 2016 Filed Nov 1, 2016 16:36 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | GrantCommon Stock | 305 | $100.98 | $30,798.90 |
DisclosureSEC source: 0001110783-16-000566 · edgar.xml · nonDerivative · entry 1 MCMILLAN CHARLES S · CIK 0001110756 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,314 F1 · shares: Represents dividend equivalents with respect to shares of deferred common stock deliverable upon termination as a director under the Monsanto Company Non-Employee Director Equity Incentive Compensation Plan. Deferred common stock and dividend equivalents are credited to a stock unit account in the form of hypothetical shares, which vest in installments on the last day of each plan month during the director's term. Shares of deferred stock that do not vest, because of termination as a director or certain changes in committee roles, are forfeited. Read SEC document |
| October 10, 2016 Filed Oct 12, 2016 16:46 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | PurchaseCommon Stock | 3,500 | $103.23 | $361,319.00 |
DisclosureSEC source: 0001110783-16-000516 · edgar.xml · nonDerivative · entry 1 MCMILLAN CHARLES S · CIK 0001110756 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,009 F1 · price: This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $103.2099 to $103.25. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| September 01, 2016 Filed Sep 6, 2016 16:53 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | GrantCommon Stock | 1,473 | $106.91 | $157,478.43 |
DisclosureSEC source: 0001110783-16-000502 · edgar.xml · nonDerivative · entry 1 MCMILLAN CHARLES S · CIK 0001110756 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,509 F1 · shares: Represents shares of deferred common stock deliverable upon termination as a director under the Monsanto Company Non-Employee Director Equity Incentive Compensation Plan. Shares of deferred stock are credited in the form of hypothetical shares to a stock unit account in installments on the last day of each plan month during the director's term. Shares of deferred stock not credited to the stock unit account because of termination as a director are forfeited. Read SEC document |
| February 22, 2005 Filed Feb 24, 2005 17:32 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | OtherPhantom Stock · Derivative | 740.38 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000070858-05-000163 · doc4.xml · derivative · entry 1 MCMILLAN CHARLES S · CIK 0001110756 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,732.58 Underlying: Common Stock · 740.38 shares Expires not disclosed F1 · kind: Units returned to the Corporation related to termination of service as a director. F2 · price: Phantom stock units may be settled in cash upon death or termination of service as a director. F2 · derivative.exercise_date: Phantom stock units may be settled in cash upon death or termination of service as a director. F2 · derivative.expiration_date: Phantom stock units may be settled in cash upon death or termination of service as a director. F3 · balance_after: Includes 126.58 phantom stock units acquired in 2004 with reinvested dividend equivalents under the Bank of America Directors' St ock Plan. F4 · balance_after: The securities included in this report and future reports reflect the Company's 2 for 1 stock split on August 27, 2004. Read SEC document |
| May 26, 2004 Filed May 27, 2004 16:04 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | GrantPhantom Stock · Derivative | 1,452.86 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000070858-04-000303 · doc4.xml · derivative · entry 1 MCMILLAN CHARLES S · CIK 0001110756 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,143.25 Underlying: Common Stock · 1,452.86 shares Expires not disclosed F1 · kind: Shares represent payment of a portion of the annual retainer fee and an additional award of restricted shares under the Bank of A merica Corporation Directors' Stock Plan in transactions exempt under Rule 16b-3. F2 · price: Phantom stock units may be settled in cash upon death or termination of service as a director. F2 · derivative.exercise_date: Phantom stock units may be settled in cash upon death or termination of service as a director. F2 · derivative.expiration_date: Phantom stock units may be settled in cash upon death or termination of service as a director. F3 · balance_after: Includes 85.61 phantom stock units acquired from June 27, 2003 to March 26, 2004 with reinvested dividend equivilents under the / bank of America Directors' Stock Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.